Grant: Engage Grants Program
University of British Columbia
$25,000.00
Concise synthesis of a sensor for Cyclophosphamide
EF 2011-12
Résumé
A recent study shows that people working in BC hospitals are exposed to chemotherapeutics, even those who
did not handle the drugs. The drugs are absorbed through dermal contact, ingestion and/or inhalation. Given
that the intent of these drugs is to kill cells, this exposure is a major problem for health-industry workers.
Unfortunately, to date, no standard protocol has been developed measure the amount of exposure for health
care workers. Cyclophosphamide is a specific example of a chemotherapeutic contaminant in BC hospitals.
This drug is used to treat a variety of cancers, including various lymphomas. Cyclophosphamide functions as
an alkylating agent, rendering it cytotoxic (i.e., it kills cells). Although killing of cancer cells is obviously
desirable, healthy cells are not immune. This leads to considerable side effects, which are worth tolerating if
you are a cancer patient, but unacceptable for those who just happen to be working in an environment where
cytotoxic drugs are administered. Of particular concern is that cyclophosphamide itself can cause certain types
of cancer. As a result, it is highly desirable to be able to detect exposure to this drug and then eradicate the
contaminant. Nanozen is working on the development of an effective air monitoring dosimeter to detect
cyclophosphamide. This requires the availability of a suitable small molecule sensor. Nanozen does not have
the expertise to synthesize such a compound and therefore wants to collaborate with Prof. Jennifer Love. Thus,
the objective of this proposal is to develop an efficient, scalable synthetic route to the small molecule sensor.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
428368-2011
Name nom
Love, Jennifer
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Concise synthesis of a sensor for Cyclophosphamide
Keyword
NSERC
Application summary
A recent study shows that people working in BC hospitals are exposed to chemotherapeutics, even those who
did not handle the drugs. The drugs are absorbed through dermal contact, ingestion and/or inhalation. Given
that the intent of these drugs is to kill cells, this exposure is a major problem for health-industry workers.
Unfortunately, to date, no standard protocol has been developed measure the amount of exposure for health
care workers. Cyclophosphamide is a specific example of a chemotherapeutic contaminant in BC hospitals.
This drug is used to treat a variety of cancers, including various lymphomas. Cyclophosphamide functions as
an alkylating agent, rendering it cytotoxic (i.e., it kills cells). Although killing of cancer cells is obviously
desirable, healthy cells are not immune. This leads to considerable side effects, which are worth tolerating if
you are a cancer patient, but unacceptable for those who just happen to be working in an environment where
cytotoxic drugs are administered. Of particular concern is that cyclophosphamide itself can cause certain types
of cancer. As a result, it is highly desirable to be able to detect exposure to this drug and then eradicate the
contaminant. Nanozen is working on the development of an effective air monitoring dosimeter to detect
cyclophosphamide. This requires the availability of a suitable small molecule sensor. Nanozen does not have
the expertise to synthesize such a compound and therefore wants to collaborate with Prof. Jennifer Love. Thus,
the objective of this proposal is to develop an efficient, scalable synthetic route to the small molecule sensor.